Cargando…
Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
BACKGROUND: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089614/ https://www.ncbi.nlm.nih.gov/pubmed/21573109 http://dx.doi.org/10.1371/journal.pone.0019604 |
_version_ | 1782203063098933248 |
---|---|
author | Fu, Shufei Zhang, Junhua Menniti-Ippolito, Francesca Gao, Xiumei Galeotti, Francesca Massari, Marco Hu, Limin Zhang, Boli Ferrelli, Rita Fauci, Alice Firenzuoli, Fabio Shang, Hongcai Guerra, Ranieri Raschetti, Roberto |
author_facet | Fu, Shufei Zhang, Junhua Menniti-Ippolito, Francesca Gao, Xiumei Galeotti, Francesca Massari, Marco Hu, Limin Zhang, Boli Ferrelli, Rita Fauci, Alice Firenzuoli, Fabio Shang, Hongcai Guerra, Ranieri Raschetti, Roberto |
author_sort | Fu, Shufei |
collection | PubMed |
description | BACKGROUND: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL). OBJECTIVES: To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge. METHODS: An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis. RESULTS: After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis. CONCLUSIONS: Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market. |
format | Text |
id | pubmed-3089614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30896142011-05-13 Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review Fu, Shufei Zhang, Junhua Menniti-Ippolito, Francesca Gao, Xiumei Galeotti, Francesca Massari, Marco Hu, Limin Zhang, Boli Ferrelli, Rita Fauci, Alice Firenzuoli, Fabio Shang, Hongcai Guerra, Ranieri Raschetti, Roberto PLoS One Research Article BACKGROUND: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL). OBJECTIVES: To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge. METHODS: An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis. RESULTS: After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis. CONCLUSIONS: Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market. Public Library of Science 2011-05-06 /pmc/articles/PMC3089614/ /pubmed/21573109 http://dx.doi.org/10.1371/journal.pone.0019604 Text en Fu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Fu, Shufei Zhang, Junhua Menniti-Ippolito, Francesca Gao, Xiumei Galeotti, Francesca Massari, Marco Hu, Limin Zhang, Boli Ferrelli, Rita Fauci, Alice Firenzuoli, Fabio Shang, Hongcai Guerra, Ranieri Raschetti, Roberto Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review |
title | Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review |
title_full | Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review |
title_fullStr | Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review |
title_full_unstemmed | Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review |
title_short | Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review |
title_sort | huangqi injection (a traditional chinese patent medicine) for chronic heart failure: a systematic review |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089614/ https://www.ncbi.nlm.nih.gov/pubmed/21573109 http://dx.doi.org/10.1371/journal.pone.0019604 |
work_keys_str_mv | AT fushufei huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT zhangjunhua huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT mennitiippolitofrancesca huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT gaoxiumei huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT galeottifrancesca huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT massarimarco huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT hulimin huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT zhangboli huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT ferrellirita huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT faucialice huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT firenzuolifabio huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT shanghongcai huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT guerraranieri huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview AT raschettiroberto huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview |